Funding








PurpleLab Raises $40M Series B from Primus Capital

  Series B Round to Accelerate PurpleLab’s Investment in Real-World Evidence Solutions Built on the Company’s HealthNexus™ Platform PurpleLab, Inc.  announced a $40 million Series B funding round led by Primus Capital, which joins existing investor Edison…


Theranica Secures $45 Million Series C Funding Round

  Proceeds to Fund U.S. Commercial Expansion of Migraine Treatment Device, Nerivio® Financing Led by Philadelphia-Based New Rhein Healthcare, Selected Additional Co-Investors to Join Round at Final Closing Theranica, a prescribed digital therapeutics company developing…